tirzepatide and vision changes Popular weight-loss drugs linked to sudden loss, research suggests vision loss tirzepatide Zepbound and

The majority of participants (61.7%) had not previously received glucose-lowering medications

Clinicians often recommend rotating injection sites, reviewing hypoglycemia precautions when used with insulin or sulfonylureas, and emphasizing missed-dose rules

For patients with type 2 diabetes, that difference in glucose control translates to meaningful clinical outcomes over time

Resolves quickly with proper fluid intake but requires ongoing vigilance Serious But Less Common Side Effects The MHRA highlights several serious but less common risks that patients should know about 1 : Gallbladder problems: Including gallstones Pancreatitis: Inflammation of the pancreas, which can require hospitalization Allergic reactions: Can include swelling, rash, and trouble breathing Low blood sugar: Can happen even in non-diabetic patients using GLP-1s for weight loss Hair loss: Some patients report temporary thinning of hair Warnings About Misuse Healthcare professionals are concerned about people using GLP-1 medications inappropriately just for cosmetic weight loss